Establishment Labs price target raised to $81 from $70 at BTIG

BTIG raised the firm’s price target on Establishment Labs (ESTA) to $81 from $70 and keeps a Buy rating on the shares. To get a better idea of Motiva adoption trends and market share shifts over the coming years, the firm conducted a brief poll of 33 U.S. plastic surgeons who perform aesthetic breast augmentations in the week following the company’s Q3 earnings call, and the polled surgeons anticipate the market will remain healthy, with procedural volumes expected to increase at a 14% CAGR from 2025-2027, the analyst tells investors in a research note.